CIK 0001136869
- Large accelerated filer
ZIMMER BIOMET HOLDINGS, INC.
Sign in to watch- Ticker
- ZBH
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 134151777
- Phone
- +1 574-267-6131
- Business address
- 345 EAST MAIN STREET, WARSAW, IN, 46580
- Former names
- ZIMMER HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $824,028
- in 2 filings
Net −$824,028. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-20 | Ellingson Rachel Chief Administrative Officer | Exercise or conversion | +1,566 | 12,397 | ||
| 2025-02-20 | Ellingson Rachel Chief Administrative Officer | Shares withheld for taxes | −491 | $103.46 | $51K | 11,906 |
| 2025-02-20 | Ellingson Rachel Chief Administrative Officer | Exercise or conversion · Restricted Stock Units | −1,566 | 3,131 | ||
| 2025-02-18 | Ellingson Rachel Chief Administrative Officer | Exercise or conversion | +5,572 | 12,623 | ||
| 2025-02-18 | Ellingson Rachel Chief Administrative Officer | Shares withheld for taxes | −1,792 | $101.00 | $181K | 10,831 |
| 2025-02-18 | Ellingson Rachel Chief Administrative Officer | Exercise or conversion · Restricted Stock Units | −5,572 | 0 | ||
| 2025-02-14 | Ellingson Rachel Chief Administrative Officer | Grant or award · Restricted Stock Units | +5,572 | 5,572 | ||
| 2024-03-06 | Ellingson Rachel SVP & Chief Strategy Officer | Exercise or conversion | +1,419 | 7,291 | ||
| 2024-03-06 | Ellingson Rachel SVP & Chief Strategy Officer | Shares withheld for taxes | −445 | $125.82 | $56K | 6,846 |
| 2024-03-06 | Ellingson Rachel SVP & Chief Strategy Officer | Exercise or conversion · Restricted Stock Units | −1,419 | 2,837 | ||
| 2024-02-25 | Ellingson Rachel SVP & Chief Strategy Officer | Exercise or conversion | +1,762 | 6,460 | ||
| 2024-02-25 | Ellingson Rachel SVP & Chief Strategy Officer | Shares withheld for taxes | −588 | $128.80 | $76K | 5,872 |
| 2024-02-25 | Ellingson Rachel SVP & Chief Strategy Officer | Exercise or conversion · Restricted Stock Units | −1,762 | 0 | ||
| 2024-02-20 | Ellingson Rachel SVP & Chief Strategy Officer | Grant or award · Restricted Stock Units | +4,697 | 4,697 | ||
| 2023-03-06 | Ellingson Rachel SVP & Chief Strategy Officer | Grant or award · Restricted Stock Units | +4,256 | 4,256 | ||
| 2023-02-21 | Ellingson Rachel SVP & Chief Strategy Officer | Exercise or conversion | +1,046 | 4,864 | ||
| 2023-02-21 | Ellingson Rachel SVP & Chief Strategy Officer | Shares withheld for taxes | −361 | $124.73 | $45K | 4,503 |
| 2023-02-21 | Ellingson Rachel SVP & Chief Strategy Officer | Exercise or conversion · Restricted Stock Units | −1,046 | 0 | ||
| 2022-05-01 | Ellingson Rachel SVP & Chief Strategy Officer | Exercise or conversion | +531 | 3,791 | ||
| 2022-05-01 | Ellingson Rachel SVP & Chief Strategy Officer | Shares withheld for taxes | −167 | $122.43 | $20K | 3,624 |
Page 1 of 2 · 24 trades